You Position: Home > Paper

Effects of low expression of CD74 on proliferation,migration and invasion of human pancreatic cancer cells

( views:131, downloads:44 )
Author:
No author available
Journal Title:
Chinese Journal of Biomedical Engineering
Issue:
5
DOI:
10.3760/cma.j.issn.1674-1927.2017.05.002
Key Word:
胰腺癌;抗原;CD74;细胞增殖;细胞迁移;侵袭;Capan-2细胞系;Pancreatic cancer;Antigens,CD74;Cell proliferation;Cell migration;Invasiveness;Capan-2 cell lines

Abstract: Objective To investigate the effect of interfering CD74 expression on the biological behavior of human pancreatic cancer cell line Capan-2. Methods The CD74-short hairpin RNA(CD74-shRNA)interference sequence was designed to construct CD74 interference plasmid transfected Capan-2 cells(group CD74-shRNA). The transfected pSUPER empty vectors were included as the controls. MTT assay was used to determine the cell proliferation activity.The scratch assay and Transwell assay were used to determine the cell migration and invasion.The real-time quantitative PCR and Western blotting were used to examine CD74 mRNA and protein expression. The real-time quantitative PCR was used to examine the mRNA expression of matrix metalloproteinase 2(MMP-2)and MMP-9. Results The cell proliferation activity test and scratch test showed that interfering CD74 expression could decrease Capan- 2 cell proliferation and inhibit cell migration(all P<0.05). The Transwell assay showed that the number of transmembrane cells in the CD74-shRNA group and the control group after culturing for 48 h were(102.5± 9.03)/well and(139.1 ± 9.89)/well,respectively,and the number in the CD74 - shRNA group was significantly lower than that in the control group(P<0.05).Compared with the control group,the inhibition rates of CD74 mRNA and protein expression in the CD74-shRNA group were 61% and 90%,respectively, and the inhibition rates of MMP-2 and MMP-9 mRNA expression in the CD74-shRNA group were 84% and 85%,respectively. Conclusion The low expression of CD74 can inhibit the proliferation,migration and invasion of Capan-2 cells.CD74 may serve as a new target for the treatment of pancreatic cancer.

WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn